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Anti-NMDA receptor antibody associated encephalitis as a cause of new-onset neuropsychiatric manifestations in children and
adults can represent a significant diagnostic challenge for clinicians. Clinical signs often include encephalopathy, new-onset
psychosis, and movement phenomenon. Although orofacial dyskinesias were initially identified as a characteristic movement
phenomenon in this type of encephalitis, an expanded range of abnormalities has recently been reported, including isolated ataxia.
We report a case of isolated hemiataxia in a young adult with mild initial psychiatric manifestations. A personal and family history
of preceding neuropsychiatric symptoms produced diagnostic confusion and resulted in a significant diagnostic and therapeutic
delay. Our case confirms the unilateral movement manifestations that have been emphasized in recent reports. Additionally, it
confirms the need for involvement of neurologic as well as psychiatric services in the evaluation of such cases and emphasizes the
importance of the neurologic examination in presentations with an initial psychiatric predominance.
1. Introduction
Anti-NMDA receptor antibody associated encephalitis is
an increasingly recognized cause of new-onset neuropsy-
chiatric manifestations in children and adults [1]. Clinical
signs often include encephalopathy, new-onset psychosis, and
movement phenomenon [2]. Although orofacial dyskinesias
were initially identified as a characteristic movement phe-
nomenon in this type of encephalitis, an expanded range of
abnormalities has recently been reported, including isolated
ataxia [3, 4]. We report a case of isolated hemiataxia in a
young adult with mild initial psychiatric manifestations. A
personal and family history of preceding neuropsychiatric
symptoms produced diagnostic confusion and resulted in
a significant diagnostic and therapeutic delay. Our case
appears to confirm the unilateral movement manifestations
that have been emphasized in recent reports [5]. Additionally,
it emphasizes the need for involvement of neurologic as well
as psychiatric services in the evaluation of such cases and
demonstrates the importance of the neurologic examination
in presentations with an initial psychiatric predominance.
2. Case Presentation
Our patient, an 18-year-old female, was referred to neurology
with a diagnosis of schizoaffective disorder after a possi-
ble first-time seizure. She had experienced previous mood
lability and attentional impairments as a teenager and had
been treated for both during that time. However, she had
been off medications for 5 years and had been doing well in
the recent past. Grades and athletic functioning were above
average, and she played three sports in high school and was
in mainstream classes. Her family history was notable for
a history of maternal depression, psychogenic nonepileptic
seizures, and anxiety, as well as a maternal grandmother with
a reported history of schizophrenia and bipolar disorder.
Eight months prior to the patient’s referral to neurology,
she experienced a self-limited illness characterized by diar-
rhea, headache, and vomiting. This was managed at home,
although she was seen by her primary care provider and
diagnosed with a viral gastroenteritis. Approximately one
month later, she began to experience insomnia,mood lability,
and weight loss. Memory issues ensued, and the parents
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reported that she began to frequently lose objects and had
difficulty remembering bus routes. Personal hygiene suffered,
and after 4 months of worsening symptoms, she began to
experience weekly episodes of urinary incontinence. There
were no other autonomic manifestations. Throughout the
course of the subacute illness, she experienced a “tremor”
of the left upper extremity when attempting to manipulate
or reach for objects, as well as dragging her left foot when
ambulating. She received ongoing psychiatric treatment and
monitoring, and her movement phenomenon was attributed
to a psychogenic cause, and a diagnosis of likely schizoaf-
fective disorder was made. After 7 months of symptoms,
she experienced a spell, characterized by clonic movements
of the left hand, followed by tonic stiffening of her entire
body, with right sided head and neck deviation, lasting 30
seconds, followed by confusion and sedation. She recovered
to baseline after 30 minutes. After this episode, she was
referred to neurology. On initial presentation to our service,
her spell was attributed to a first-time seizure by history.
Mental status examination demonstrated a distracted and
labile demeanor. Cognition was impaired on both bedside
and formal neuropsychological testing with impairments in
memory, attention, and reasoning. Neurologic examination
demonstrated left sided dysmetria as well as gait disturbance
arising from left lower extremity coordination impairment.
MRI of the brain revealed increased FLAIR signal of the
left hippocampus. No cerebellar or contralateral brain find-
ings were identified as potential substrate for her unilateral
ataxia. Electroencephalogram was normal. The combination
of her ataxia, cognitive decline, and incontinence prompted
an extensive laboratory evaluation for systemic conditions
as well as inborn errors of metabolism. Spinal tap was
performed, with testing for autoimmune and inflammatory
conditions. Testing was positive only for the presence of
NMDA receptor antibodies in the spinal fluid (NMDA-R Ab
IF Titer Assay, CSF Positive 1 : 4 and reference < 1 : 2, Mayo
Clinic Laboratories) with no evidence of active infection or
inflammation. Extensive evaluation for a neoplastic substrate,
specifically ovarian teratoma, was negative. Because of the
extended course experienced by the patient she was started
on an aggressive regimen of immune modulation, includ-
ing concurrent intravenous immunoglobulin, IV methyl-
prednisolone, and rituximab. Although her parents report
that psychiatric symptoms were improving after 3 months
of treatment, she continues to require medical treatment
for her psychiatric manifestations and has been unable to
return to school or employment. Additionally, her movement
abnormalities persist.
3. Discussion
Anti-NMDA receptor antibody encephalitis is increasingly
identified as an etiology for noninfectious encephalitis in
children and adults [6]. A classic presentation of the con-
dition would be acute onset psychosis/encephalopathy with
associated orofacial dyskinesias, without clear precipitant or
injury, leading to progressive decline and coma in some
[7]. Tumor as a substrate for a paraneoplastic etiology is
not uncommon [8]. As awareness of the condition has
grown, a broadening of the phenotype has become evident,
associated in some with seizures and gait disturbances [9,
10]. Importantly, a growing number of movement disorders
have been identified as well [4, 10–12]. Our patient’s initial
presentation with new-onset “tremor” in association with
psychiatric decline is characteristic in that there was a clear
association with movement phenomenon and neurobehav-
ioral deterioration. However, to our knowledge, a unilateral
presentation of ataxia has not been described to date. Move-
ment phenomena in children and adults with psychiatric
conditions are not uncommon and include tic, stereotypy,
chorea, and drug induced dyskinesias [13, 14]. Depending
on the etiologic substrate, these manifestations may be of
variable degree and sometimes subtle in their presentation,
with psychiatric signs outweighing manifestations of move-
ment impairment [15, 16]. A detailed neurologic examination
is therefore indicated in all individuals with unexplained
neuropsychiatric presentations, especially if clinical signs
indicate neurologic dysfunction beyond isolated psychiatric
impairments [17]. Our patient’s manifestations of ataxia were
initially ascribed to psychogenic tremor, and coordination
disturbances can appear to be semirhythmic in character (as
with tremor) as the patient attempts to reach a target in
the environment. However, a variety of means can be used
to identify the clear disturbance in amplitude modulation
seen in ataxia/dysmetria, such as repetitive finger to object
testing or testing of the ability to rhythmically and quickly
modify hand position (finger, hand tapping, etc.). Ataxia
is a common, nonspecific accompaniment of a number of
congenital, posttraumatic, metabolic, and autoimmune con-
ditions [18]. Manifestations can be bilateral or unilateral and
variably affect the appendicular or axial musculature. Signs
are typically related to a dysfunction of amplitude of move-
ment and coordination, often leading to gait disturbance and
impairments of fine motor functioning. Although typically
localized to the cerebellum, ataxia may occur resulting from
injury to a variety of neuroanatomic regions. Because it may
be semirhythmic as the patient attempts to correct the move-
ment trajectory, it can be confused with tremor. The coarse
and variable amplitude in some may also be reminiscent of
a psychogenic manifestation [19]. Formal neurologic exam-
ination at 8 months of symptoms demonstrated, however, a
clear isolated dysmetria affecting the left upper extremity and
mild left sided ataxia. In our case, the abnormal movements
were initially attributed to a psychogenic etiology. Although
psychogenic movement disorders are common, the manifes-
tations of this patient upon formal neurologic evaluationwere
clearly attributable to a neurologic etiology.The combination
of a unilateral movement abnormality in association with
the psychiatric manifestations placed her case outside the
realm of an isolated psychiatric condition and warranted
further diagnostic evaluation. Our case emphasizes both the
expanded spectrumofmovement phenomenon thatmight be
seen in cases of anti-NMDA receptor antibody encephalitis
and the variability of the encephalopathy at presentation and
throughout the course. Additionally, recent reports indicate
a propensity for unilateral presentations of the movement
phenomenon as was clearly demonstrated in our patient with
more than 8 months of hemiataxia without contralateral
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findings [5]. Testing for anti-NMDA antibody disorders has
become readily available, with serum and spinal fluid analysis
typically demonstrating positivity in affected individuals.
The presence of the antibodies themselves is considered
pathologic, and the autoimmune dysregulation that underlies
this condition appears to be triggered by a number of
precipitants, including paraneoplastic and infectious entities
[20]. Treatment for the autoimmune disorder ismost effective
when initiated early in the course, and, unfortunately, our
patient was not diagnosed until approximately 8 months
after disease onset. This may portend a more challenging
prognosis, and a possible increased rate of disease recurrence
and permanent neuropsychiatric deficits were discussed with
the family as a result [21]. Additionally, screening for a
neoplastic substrate is important as early recognition and
treatment of an underlying tumor may improve neurologic
outcome. Treatment of these conditions typically involves a
combination of immunosuppressive and immunomodulat-
ing agents in hopes of decreasing abnormal antibody produc-
tion and eliminating the harmful effects of antibodies already
circulating [22]. Improvements are typically seen within days
to weeks. However, a prolonged course refractory to medical
therapy is possible, and multiple agents for immune suppres-
sion may be necessary. At present, formal recommendations
regarding duration of therapy are unknown [1]. A significant
number of patients relapse, indicating that there may be
justification for indefinite treatment in some individuals.
Our patient had mild preexisting manifestations of psy-
chiatric difficulties, as is commonly seen in the general pop-
ulation in childhood, including attentional challenges and
anxiety. These were not disabling for this patient and she was
functioning appropriately, performing well in academics and
athletics. Additional challenging historical aspects included a
positive family history of psychiatric conditions in a number
of relatives, which suggested a familial etiology in this
individual. Although a familial predisposition is often sought
in psychiatric and neurologic conditions, caution should be
exercised when attributing this to causation of symptoms in
the proband [23]. There is the possibility that a propensity
to an autoimmune substrate underlies psychiatric illness in
some families, although this remains to be evaluated.
Our case emphasizes the need for a high index of
suspicion for medical conditions in patients with new-
onset psychiatric deterioration in childhood and adulthood.
Confusing aspects, as in this case, may include a positive
family history, or a relatively static or slowly deteriorating
course, rather than a catastrophic presentation with acute
psychosis progressing to a profound depression of level of
consciousness. Inborn errors of metabolism can also present
at any age with predominantly psychiatric manifestations
and should be included in the differential diagnosis [24].
An important characteristic in any patient with psychiatric
manifestations would be the cooccurrence of a movement
phenomenon. Additionally, the unilateral nature of her man-
ifestations raises concern regarding an underlying lesion
that would necessitate, at the least, neuroimaging. This
case also appears to confirm a propensity for unilateral
symptoms in this condition as has been previously reported
[5]. As noted, psychiatric conditions may be associated with
comorbid movement disorders such as tic as in Tourette and
stereotypy in autism. Conditions outside of these common
comorbidmovement disorders, such as ataxia, myoclonus, or
Parkinsonism, should prompt further evaluation and referral
to a neurologist. This case emphasizes the need for close
coordination with neurology, psychiatry, and psychological
services in situations when there is a possibility of an
underlying identifiable neurologic substrate [25, 26].
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Supplementary Materials
Video demonstrating initial examination findings and
changes during treatment course. At the time of initial
evaluation, the patient demonstrates significant dysmetria
on left sided finger to object testing. Gait demonstrates
hypertonia of the ipsilateral leg with circumduction.
As treatment is started she has improvements in the
amplitude of the dysmetria, with more exact targeting.
Symptoms persist however despite aggressive treatment.
(Supplementary Materials)
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